Your browser doesn't support javascript.
loading
The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies.
Kalk, N J; Nutt, D J; Lingford-Hughes, A R.
Affiliation
  • Kalk NJ; Department of Psychopharmacology, University of Bristol, Bristol, UK. nicola.kalk@bristol.ac.uk
J Psychopharmacol ; 25(1): 3-16, 2011 Jan.
Article in En | MEDLINE | ID: mdl-20530586
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Norepinephrine / Receptors, Adrenergic, alpha-2 / Adrenergic Uptake Inhibitors Limits: Humans Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Norepinephrine / Receptors, Adrenergic, alpha-2 / Adrenergic Uptake Inhibitors Limits: Humans Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country: